Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
GD2/CD70 Bi-specific CAR-T Cell TherapyneoplasmNot yet recruitingPhase 1 / Phase 22026-08-26NCT05438368

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Shenzhen Geno-Immune Medical Institute43

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Shenzhen Geno-Immune Medical InstituteShenzhenChina39